By: Tom Spiggle , THE SPIGGLE LAW FIRM, PLLC Artificial intelligence (AI) isn’t new, but AI technology that’s good enough to catch the attention of the average person and affect their daily lives is rather novel. A great example of such...

By: Christopher Campbell and Antonious Sadek , DLA PIPER This checklist provides guidance for protecting attorney-client privilege and work product in the environment of generative artificial intelligence (AI). The checklist specifically gives an...

By: Michael Furrow and Shannon Clark , Fitzpatrick, Cella, Harper & Scinto                                            ...

By: Chad A. Landmon and Suzanne E. Bassett , POLSINELLI PC THIS ARTICLE PROVIDES GUIDANCE ON THE IMPACT of the U.S. Supreme Court’s recent decisions in Loper Bright 1 and Corner Post 2 on decision-making by the U.S. Food and Drug Administration...

By: Scott Bass and Deeona Gaskin , Sidley Austin LLP This article addresses key topics related to the management of data by drug, biologic, and medical device companies whose products are regulated by the U.S. Food and Drug Administration (FDA). This...